Materials Map

Discover the materials research landscape. Find experts, partners, networks.

  • About
  • Privacy Policy
  • Legal Notice
  • Contact

The Materials Map is an open tool for improving networking and interdisciplinary exchange within materials research. It enables cross-database search for cooperation and network partners and discovering of the research landscape.

The dashboard provides detailed information about the selected scientist, e.g. publications. The dashboard can be filtered and shows the relationship to co-authors in different diagrams. In addition, a link is provided to find contact information.

×

Materials Map under construction

The Materials Map is still under development. In its current state, it is only based on one single data source and, thus, incomplete and contains duplicates. We are working on incorporating new open data sources like ORCID to improve the quality and the timeliness of our data. We will update Materials Map as soon as possible and kindly ask for your patience.

To Graph

1.080 Topics available

To Map

977 Locations available

693.932 PEOPLE
693.932 People People

693.932 People

Show results for 693.932 people that are selected by your search filters.

←

Page 1 of 27758

→
←

Page 1 of 0

→
PeopleLocationsStatistics
Naji, M.
  • 2
  • 13
  • 3
  • 2025
Motta, Antonella
  • 8
  • 52
  • 159
  • 2025
Aletan, Dirar
  • 1
  • 1
  • 0
  • 2025
Mohamed, Tarek
  • 1
  • 7
  • 2
  • 2025
Ertürk, Emre
  • 2
  • 3
  • 0
  • 2025
Taccardi, Nicola
  • 9
  • 81
  • 75
  • 2025
Kononenko, Denys
  • 1
  • 8
  • 2
  • 2025
Petrov, R. H.Madrid
  • 46
  • 125
  • 1k
  • 2025
Alshaaer, MazenBrussels
  • 17
  • 31
  • 172
  • 2025
Bih, L.
  • 15
  • 44
  • 145
  • 2025
Casati, R.
  • 31
  • 86
  • 661
  • 2025
Muller, Hermance
  • 1
  • 11
  • 0
  • 2025
Kočí, JanPrague
  • 28
  • 34
  • 209
  • 2025
Šuljagić, Marija
  • 10
  • 33
  • 43
  • 2025
Kalteremidou, Kalliopi-ArtemiBrussels
  • 14
  • 22
  • 158
  • 2025
Azam, Siraj
  • 1
  • 3
  • 2
  • 2025
Ospanova, Alyiya
  • 1
  • 6
  • 0
  • 2025
Blanpain, Bart
  • 568
  • 653
  • 13k
  • 2025
Ali, M. A.
  • 7
  • 75
  • 187
  • 2025
Popa, V.
  • 5
  • 12
  • 45
  • 2025
Rančić, M.
  • 2
  • 13
  • 0
  • 2025
Ollier, Nadège
  • 28
  • 75
  • 239
  • 2025
Azevedo, Nuno Monteiro
  • 4
  • 8
  • 25
  • 2025
Landes, Michael
  • 1
  • 9
  • 2
  • 2025
Rignanese, Gian-Marco
  • 15
  • 98
  • 805
  • 2025

Harrison, C.

  • Google
  • 2
  • 17
  • 92

in Cooperation with on an Cooperation-Score of 37%

Topics

Publications (2/2 displayed)

  • 2024The Medicines Optimisation Innovation Centre: a dedicated centre driving innovation in medicines optimisation-impact and sustainability4citations
  • 2013The Spitzer Mid-infrared Active Galactic Nucleus Survey. I. Optical and Near-infrared Spectroscopy of Obscured Candidates and Normal Active Galactic Nuclei Selected in the Mid-infrared88citations

Places of action

Chart of shared publication
Martin, Suzanne
1 / 5 shared
Scott, Michael
1 / 1 shared
Hogg, Anita
1 / 1 shared
Huey, Rachel
1 / 1 shared
Goodfellow, Nicola
1 / 1 shared
Fleming, Glenda
1 / 1 shared
Scullin, Claire
1 / 1 shared
Ridgway, S. E.
1 / 1 shared
Gates, E. L.
1 / 1 shared
Lacy, M.
1 / 1 shared
Storrie-Lombardi, L. J.
1 / 1 shared
Sajina, A.
1 / 1 shared
Nielsen, D. M.
1 / 1 shared
Petric, A. O.
1 / 1 shared
Seymour, N.
1 / 1 shared
Cox Drews, S.
1 / 1 shared
Urrutia, Tanya
1 / 2 shared
Chart of publication period
2024
2013

Co-Authors (by relevance)

  • Martin, Suzanne
  • Scott, Michael
  • Hogg, Anita
  • Huey, Rachel
  • Goodfellow, Nicola
  • Fleming, Glenda
  • Scullin, Claire
  • Ridgway, S. E.
  • Gates, E. L.
  • Lacy, M.
  • Storrie-Lombardi, L. J.
  • Sajina, A.
  • Nielsen, D. M.
  • Petric, A. O.
  • Seymour, N.
  • Cox Drews, S.
  • Urrutia, Tanya
OrganizationsLocationPeople

article

The Medicines Optimisation Innovation Centre: a dedicated centre driving innovation in medicines optimisation-impact and sustainability

  • Martin, Suzanne
  • Scott, Michael
  • Hogg, Anita
  • Huey, Rachel
  • Harrison, C.
  • Goodfellow, Nicola
  • Fleming, Glenda
  • Scullin, Claire
Abstract

<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Sub-optimal medicines use is a challenge globally, contributing to poorer health outcomes, inefficiencies and waste. The Medicines Optimisation Innovation Centre (MOIC) was established in Northern Ireland by the Department of Health (DH) in 2015 to support implementation of the Medicines Optimisation Quality Framework.</jats:p></jats:sec><jats:sec><jats:title>Aim</jats:title><jats:p>To demonstrate how MOIC informs policy and provides support to commissioners to improve population health and wellbeing.</jats:p></jats:sec><jats:sec><jats:title>Setting</jats:title><jats:p>MOIC is a regional centre with multidisciplinary and multi-sector clinical expertise across Health and Social Care and patient representation.</jats:p></jats:sec><jats:sec><jats:title>Development</jats:title><jats:p>Core funded by DH, MOIC has a robust governance structure and oversight programme board. An annual business plan is agreed with DH. Rigorous processes have been developed for project adoption and working collaboratively with industry.</jats:p></jats:sec><jats:sec><jats:title>Implementation</jats:title><jats:p>MOIC has established partnerships with academia, industry, healthcare and representative organisations across Europe, participating in research and development projects and testing integrated technology solutions. A hosting programme has been established and evaluation and dissemination strategies have been developed.</jats:p></jats:sec><jats:sec><jats:title>Evaluation</jats:title><jats:p>MOIC has established numerous agreements, partnered in three large EU projects and strengthened networks globally with extensive publications and conference presentations. Informing pathway redesign, sustainability and COVID response, MOIC has also assisted in the development of clinical pharmacy services and antimicrobial stewardship in Europe and Africa. Northern Ireland has been recognised as a 4-star European Active and Healthy Ageing Reference Site and the Integrated Medicines Management model as an example of best practice in Central and Eastern Europe.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>MOIC has demonstrated considerable success and sustainability and is applicable to health systems globally.</jats:p></jats:sec>

Topics
  • impedance spectroscopy
  • aging
  • size-exclusion chromatography